Next-generation sequencing (NGS) in patients (pts) with metastatic colorectal cancer (mCRC): novel mutated genes and differential response to therapy (Alliance)
      Google Scholar   
Citation:
Annals of Oncology vol 30 (Supplement_5) v198–v199
Meeting Instance:
ESMO 2019
Year:
2019
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3663  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Genentech, Eli Lily & Co., Pfizer, Sanofi  
Grants:
U10CA180821, U10CA180882, U10CA180888 and U10CA180830 (SWOG);  
Corr. Author:
 
Authors:
                       
Networks:
CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, OR013   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: